BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12235215)

  • 1. Inhibition of type 1 cytokine-mediated inflammation by a soluble CD30 homologue encoded by ectromelia (mousepox) virus.
    Saraiva M; Smith P; Fallon PG; Alcami A
    J Exp Med; 2002 Sep; 196(6):829-39. PubMed ID: 12235215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A method for the generation of ectromelia virus (ECTV) recombinants: in vivo analysis of ECTV vCD30 deletion mutants.
    Alejo A; Saraiva M; Ruiz-Argüello MB; Viejo-Borbolla A; de Marco MF; Salguero FJ; Alcami A
    PLoS One; 2009; 4(4):e5175. PubMed ID: 19365546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency in Th2 cytokine responses exacerbate orthopoxvirus infection.
    Sakala IG; Chaudhri G; Eldi P; Buller RM; Karupiah G
    PLoS One; 2015; 10(3):e0118685. PubMed ID: 25751266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of HIV expression by CD30 triggering in CD4+ T cells from HIV-infected individuals.
    Maggi E; Annunziato F; Manetti R; Biagiotti R; Giudizi MG; Ravina A; Almerigogna F; Boiani N; Alderson M; Romagnani S
    Immunity; 1995 Aug; 3(2):251-5. PubMed ID: 7648397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-expression of CD30 ligand and interleukin 4 (IL-4) receptors by acute myeloid leukaemia blasts is associated with the expansion of IL-4-producing CD30+ normal T cells.
    Rossi FM; Degan M; Mazzocco FT; Di Francia R; Aldinucci D; Poletto D; Vellenga E; Pinto A; Gattei V
    Br J Haematol; 2002 Apr; 117(1):59-69. PubMed ID: 11918534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD30-mediated signaling promotes the development of human T helper type 2-like T cells.
    Del Prete G; De Carli M; D'Elios MM; Daniel KC; Almerigogna F; Alderson M; Smith CA; Thomas E; Romagnani S
    J Exp Med; 1995 Dec; 182(6):1655-61. PubMed ID: 7500010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD30 ligand, a member of the TNF ligand superfamily, with growth and activation control CD30+ lymphoid and lymphoma cells.
    Gruss H-J ; Herrmann F
    Leuk Lymphoma; 1996 Feb; 20(5-6):397-409. PubMed ID: 8833395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD30 ligand (CD30L)-expressing acute myeloid leukemias: a new model of paracrine interactions for the regulation of blast cells proliferation.
    Gattei V; Degan M; Rossi FM; de Iuliis A; Mazzocco FT; Serraino D; Zagonel V; Aldinucci D; Pinto A
    Leuk Lymphoma; 1999 Sep; 35(1-2):21-35. PubMed ID: 10512160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response.
    Pellegrini P; Berghella AM; Contasta I; Adorno D
    Transpl Immunol; 2003; 12(1):49-61. PubMed ID: 14551032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox.
    Jackson RJ; Ramsay AJ; Christensen CD; Beaton S; Hall DF; Ramshaw IA
    J Virol; 2001 Feb; 75(3):1205-10. PubMed ID: 11152493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox.
    Chaudhri G; Panchanathan V; Buller RM; van den Eertwegh AJ; Claassen E; Zhou J; de Chazal R; Laman JD; Karupiah G
    Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9057-62. PubMed ID: 15184649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD30L up-regulates CD30 and IL-4 expression by T cells.
    Rossi FM; Degan M; Mazzocut-Zecchin L; Di Francia R; Aldinucci D; Pinto A; Gattei V
    FEBS Lett; 2001 Nov; 508(3):418-22. PubMed ID: 11728464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cowpox virus encodes a fifth member of the tumor necrosis factor receptor family: a soluble, secreted CD30 homologue.
    Panus JF; Smith CA; Ray CA; Smith TD; Patel DD; Pickup DJ
    Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8348-53. PubMed ID: 12034885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
    Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y
    Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and regulation of CD30 ligand and CD30 in human leukemia-lymphoma cell lines.
    Gruss HJ; DaSilva N; Hu ZB; Uphoff CC; Goodwin RG; Drexler HG
    Leukemia; 1994 Dec; 8(12):2083-94. PubMed ID: 7528856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD30 mRNA, CD30L mRNA and a variant form of CD30 mRNA in restimulated peripheral blood mononuclear cells (PBMC) of patients with helminthic infections resembling a Th2 disease.
    Kilwinski J; Berger T; Mpalaskas J; Reuter S; Flick W; Kern P
    Clin Exp Immunol; 1999 Jan; 115(1):114-9. PubMed ID: 9933429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD30 ligand/CD30 interaction is involved in pathogenesis of inflammatory bowel disease.
    Somada S; Muta H; Nakamura K; Sun X; Honda K; Ihara E; Akiho H; Takayanagi R; Yoshikai Y; Podack ER; Tani K
    Dig Dis Sci; 2012 Aug; 57(8):2031-7. PubMed ID: 22451116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD30 ligand/CD30 plays a critical role in Th17 differentiation in mice.
    Sun X; Yamada H; Shibata K; Muta H; Tani K; Podack ER; Yoshikai Y
    J Immunol; 2010 Aug; 185(4):2222-30. PubMed ID: 20639486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and expression of a soluble form of human CD30 ligand with functional activity.
    Powell IF; Li T; Jäck HM; Ellis TM
    J Leukoc Biol; 1998 Jun; 63(6):752-7. PubMed ID: 9620669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of host response modifier ORFs of ectromelia virus, the causative agent of mousepox.
    Chen N; Buller RM; Wall EM; Upton C
    Virus Res; 2000 Feb; 66(2):155-73. PubMed ID: 10725549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.